Tinzaparin sodium
Sponsors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, National Institute of Neurological Disorders and Stroke (NINDS), University of Calgary, University of Vermont, University of Southern California
Conditions
CancerIschemic StrokeKidney CancerLung NeoplasmThromboembolismThrombosisVaricose VeinsVenous Thromboembolism
Phase 1
Phase 2
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
CompletedNCT00061373
Start: 2003-05-31End: 2011-07-31Updated: 2013-02-04
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
TerminatedNCT00981903
Start: 2005-07-31End: 2015-10-31Updated: 2017-07-06
Prevention of venous thromboembolism in cirrhotic patients with hepatocellular carcinoma
Not yet recruitingCTIS2026-526857-33-00
Target: 70Updated: 2026-09-17
Phase 3
Phase 4
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
CompletedNCT00203658
Start: 1997-04-30End: 2000-10-31Target: 400Updated: 2007-02-09
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
CompletedNCT00203580
Start: 1994-12-31End: 2002-03-31Target: 910Updated: 2007-02-09
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
RecruitingNCT05735639
Start: 2024-01-22End: 2027-12-31Target: 3175Updated: 2026-06-04